Main menu:
TIGO GmbH
Technology: hIFN-y receptor antagonists
Technology: IFN-beta
Intellectual Property
Indication: Graft Arteriosclerosis
Indication: Alopecia Areata
Management
Cooperations & Partnering
Contact & Impressum
Expand all | Compact all